Alison Isherwood
Director, Epidemiology & Real-World Evidence
Dr. Alison Isherwood is a Director in Clarivate’s Commercial Strategy Consulting Epidemiology & Real-World Evidence team.
Alison has over 16 years of consultancy experience in healthcare and life sciences consultancy, specializing in epidemiological and RWE-based insights and solutions. Her role is to use secondary data and US and European real-world data (RWD) to provide strategic epidemiological insights for business stakeholders in commercial and HEOR roles.
Alison held the roles of Research Scientist at Evidera designing and executing RWE-based outcomes research studies. Prior to this, she the Director of Epidemiology for DRG’s Syndicated Epidemiology team where she gained considerable experience in patient population sizing with incidence and prevalence risk-based forecast modelling across a portfolio of 200 diseases in over 40 countries.
She holds a Doctoral degree from the University of Reading (UK), and an MSc in Epidemiology, an MRes in Life Sciences and a BSc in Medical Microbiology all from the University of Edinburgh.
Latest news
Clarivate to Report Fourth Quarter and Full Year 2025 Results on February 24, 2026
London, U.K., January 28, 2026 – (PR Newswire) – Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced it will report its financial results for the fourth…
Clarivate Introduces Nexus, Connecting AI Users to Trusted Academic Resources
Clarivate Nexus integrates academic content and services into the AI tools increasingly used by students and researchers, helping libraries and institutions remain central to trusted scholarship. LONDON, UK — January…
